ATAGI Revises COVID-19 Vaccination Recommendations for Children and Adolescents

This shift reflects ATAGI’s updated assessment that the risks of COVID-19 vaccination in this low-risk population now outweigh the potential benefits. COVID-19 poses a minimal threat to healthy children, and this change aligns with international trends toward re-evaluating the use of these vaccines in younger populations.

ATAGI’s revised guidelines continue to recommend vaccination only for children and adolescents aged 5–17 years who have severe immunocompromise or complex medical conditions that place them at higher risk of severe illness from COVID-19.

Despite the major implications of this decision, the government has not issued a formal public announcement. This stands in stark contrast to the high-profile campaigns that accompanied the initial rollout of COVID-19 vaccines for children. It has come to our attention that many doctors across Australia remain unaware of this critical update.

We urge all medical practitioners to immediately review the updated ATAGI guidelines and ensure their vaccination practices reflect the most current evidence and policy.

AMPS Calls for a National Moratorium on COVID-19 and mRNA Vaccines

 The Australian Medical Professionals' Society (AMPS) continues to call for a full moratorium on all COVID-19 and mRNA vaccines due to continuing significant concerns over their safety profile. The number of associated deaths and adverse events reported in Australia and globally is unprecedented for any vaccination program in modern history.